Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001679593-16-000001
Filing Date
2016-07-20
Accepted
2016-07-20 16:52:09
Documents
1
Effectiveness Date
2016-07-20
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 5779
  Complete submission text file 0001679593-16-000001.txt   6843
Mailing Address 1225 LAUREL STREET SUITE 213 COLUMBIA SC 29201
Business Address 1225 LAUREL STREET SUITE 213 COLUMBIA SC 29201 8035450075
Synapsin Pharmaceuticals, Inc. (Filer) CIK: 0001679593 (see all company filings)

EIN.: 060329603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-267417 | Film No.: 161775917